Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic review of mRNA expression in human oocytes: understanding the molecular mechanisms underlying oocyte competence. | J Assist Reprod Genet | 2023 | 37558907 | PubTator, text mining | PubMed |
| Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial. | BMC Cancer | 2023 | 37550634 | PubTator, text mining | PubMed |
| APOE4/4 is linked to damaging lipid droplets in Alzheimer's microglia. | bioRxiv | 2023 | 37546938 | PubTator, text mining | PubMed |
| Efficacy of concurrent chemoradiotherapy with thalidomide and S-1 for esophageal carcinoma and its influence on serum tumor markers. | World J Gastrointest Oncol | 2023 | 37546558 | PubTator, text mining | PubMed |
| Perceived dignity is an unrecognized source of emotional distress in patients with rheumatic diseases: Results from the validation of the Mexican version of the Patient Dignity Inventory. | PLoS One | 2023 | 37540659 | PubTator, text mining | PubMed |
| Effect of silkworm pupae (Bombyx mori) protein on colon cancer in nude mice: inhibition of tumor growth, oxidative stress and inflammatory response. | Front Pharmacol | 2023 | 37538184 | PubTator, text mining | PubMed |
| Clinicopathological characteristics and postoperative prognosis of patients with nuclear pedigree of esophageal squamous cell carcinoma. | Front Oncol | 2023 | 37538122 | PubTator, text mining | PubMed |
| Colorectal cancer and therapy response: a focus on the main mechanisms involved. | Front Oncol | 2023 | 37538108 | PubTator, text mining | PubMed |
| BEDwARS: a robust Bayesian approach to bulk gene expression deconvolution with noisy reference signatures. | Genome Biol | 2023 | 37537644 | PubTator, text mining | PubMed |
| Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping. | Pharmgenomics Pers Med | 2023 | 37534027 | PubTator, text mining | PubMed |
| Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes. | Mol Cancer | 2023 | 37516818 | PubTator, text mining | PubMed |
| Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives. | J Clin Med | 2023 | 37510761 | PubTator, text mining | PubMed |
| Cytochrome P2E1 (CYP2E1) Gene Polymorphism as a Potential Prognostic Biomarker in Colorectal Cancer. | Asian Pac J Cancer Prev | 2023 | 37505752 | PubTator, text mining | PubMed |
| Radiation-Induced Oropharyngeal Squamous Cell Carcinoma: Case Report and Review of the Literature. | Curr Oncol | 2023 | 37504352 | PubTator, text mining | PubMed |
| Circadian rhythm as a key player in cancer progression as well as a therapeutic target in HER2-positive advanced gastric cancer treatment. | Front Oncol | 2023 | 37503323 | PubTator, text mining | PubMed |
| Two patients with fluoropyrimidine overdose successfully managed without uridine triacetate. | J Oncol Pharm Pract | 2023 | 37499216 | PubTator, text mining | PubMed |
| DeepGenePrior: A deep learning model for prioritizing genes affected by copy number variants. | PLoS Comput Biol | 2023 | 37486921 | PubTator, text mining | PubMed |
| Transient Coma and Signs of Encephalopathy Related to 5-Fluorouracil and Carboplatin: A Case Report. | Case Rep Oncol | 2023 | 37485017 | PubTator, text mining | PubMed |
| Computational pharmacogenotype extraction from clinical next-generation sequencing. | Front Oncol | 2023 | 37469403 | PubTator, text mining | PubMed |
| Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects. | Cancer Drug Resist | 2023 | 37457133 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=23